Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (6272)	5/6/2002 2:12:50 PM
From: Ian@SI	Read Replies (1) of 52153

I'm neutral on ICOS. Peter, Would you shed a little light on this stance? With the approvable letter, it's closer to Cialis approval than it ever was when the stock was at a much higher price. Its pipeline has 3 distinct Sepsis prospects. Xigris only addresses 26% of this large market and hasn't been setting the drug world on fire so far. Seems to me that the market may well have overshot to the downside as long as one is prepared to be patient for the next year or so. ??? Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next